The New  Jersey Supreme Court has blocked a Merck shareholder’s plans for a deep dive into the company’s records related to the acquisition of another drug company.

R.A. Feuer, who owns 288 shares of Merck stock and has threatened to bring a shareholder derivative action against the company, sought records related to its 2015 acquisition of Cubist Pharmaceuticals for $9.5 billion. But the Supreme Court rejected Feuer’s document request, finding that a state law allowing shareholders of a corporation to inspect “books and records of account” does not encompass all records, books and documents of a corporation. The court also found that the circumstances of the case, including Feuer’s claim that Merck overpaid for the Cubist acquisition, did not support his argument for common-law access to company records.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]